Cinacalcet for hyperparathyroidism in pregnancy and puerperium

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 8, 2009, Pages 741-749

  Horjus, Carmen ^a   Groot, Inge ^a   Telting, Darryl ^a   Van Setten, Petra ^a   Van Sorge, Adriaan ^a   Kovacs, Christopher S ^b   Hermus, Ad ^c   De Boer, Hans ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cinacalcet; Hyperparathyroidism; Pregnancy

Indexed keywords

CALCITONIN; CALCIUM; CINACALCET; VITAMIN D;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; DRUG DOSE INCREASE; FEMALE; FETUS MONITORING; HUMAN; HYPERPARATHYROIDISM; INFANT; LABORATORY TEST; NEWBORN INTENSIVE CARE; PARATHYROID ADENOMA; PREGNANCY; PUERPERIUM;

EID: 70349509836     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.8.741     Document Type: Article

References (30)

1. Palmer M, Jakobsson S, Åkerström G, Ljunghall S. Prevalence of hypercalcemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 1988; 18: 39-46. (Pubitemid 18167812)
2. Jorde R, Bönaa KH, Sundsfjord J. Primary hyperparathyroidism detected in a health screening. The Tromsö study. J Clin Epidemiol 2000; 53: 1164-1169.
3. Christensson T, Hellström K, Wengle B, Alveryd A, Wikland B. Prevalence of hypercalcemia in a health screening in Stockholm. Acta Med Scand 1976; 200: 131-137.
4. Bevere L, Sorrentino B. Contributo allo studio dell' osteite fibrocystica generalizzata. Riforma Med 1932; 48: 313-318.
5. Ludwig GD. Hyperparathyroidism in relation to pregnancy. N Engl J Med 1962; 267: 637-642.
6. Shangold MM, Dor N, Welt SI, Fleischman AR, Crenshaw MC Jr. Hyperparathyroidism and pregnancy: a review. Obstet Gynecol Surv 1982; 37: 217-228.
7. Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 2002; 57: 365-376.
8. Schnatz PF, Thaxton S. Parathyroidectomy in the third trimester of pregnancy. Obstet Gynecol Surv 2005; 10: 672-682.
9. Goodman S. Anesthesia for nonobstetric surgery in the pregnant patient. Semin Perinatol 2002; 26: 136-145. (Pubitemid 34438399)
10. Sjöberg HE, Hjern B. Acute treatment with calcitonin in primary hyperparathyroidism and severe hypercalcemia of other origin. Acta Chir Scand 1975; 141: 90-95.
11. Cruikshank DP, Pitkin RM. Donnelly E, Reynolds WA. Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion. Obstet Gynecol 1981; 58: 430-434. (Pubitemid 12232148)
12. Vernava AM, O'Neal LW, Palermo V. Lethal hyperparathyroid crisis: hazards of phosphate administration. Surgery 1987; 102: 941-948. (Pubitemid 18010739)
13. Phitayakorn R, McHenry CR. Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J Am Coll Surg 2008; 206: 1106-11105
14. Culbert EC, Schfirin BS. Malignant hypercalcemia in pregnancy. Effects of pamidronate on uterine contractions. Am Coll Obstet Gynecol 2006; 108: 789-791.
15. Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003; 88: 5644. (Pubitemid 38033028)
16. Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochoride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2005; 90: 135-141. (Pubitemid 40116646)
17. Kovacs CS, Fuleihan GEH. Calcium and bone metabolism during pregnancy and lactation. Endocrinol Metab Clin North Am 2006; 35: 21-51. (Pubitemid 41668866)
18. Lindheimer MD, Katz AI. Renal physiology and disease in pregnancy. In: Seldin DW, Giebisch G, eds. The Kidney, Physiology and Pathophysiology. New York: Raven Press, 1992; 3371-3431.
19. Nagano N. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Pharmacol Ther 2006; 109: 339-365. (Pubitemid 43132817)
20. Amgen. Sensipar drug leaflet, 2008.
21. Watanabe T, Bai M, Lane CR, Matsumoto S, Minamitani K, Minagawa M, Niimi H, Brown EM, Yasuda T. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor. J Clin Endocrinol Metab 1998; 83: 2497-2502. (Pubitemid 28503053)
22. Lienhardt A, Garabedian M, Bai M, Sinding C, Zhang Z, Lagarde JP, Boulesteix J, Rigaud M, Brown EM, Kottler ML. A large homozygous or heterozygous inframe deletion within the calcium-sensing receptor's carboxyterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2000; 85: 1695-1702. (Pubitemid 32289521)
23. Hirai H, Nakajima S, Miyauchi A, Nishimura K, Shimizu N, Shima M, Michigami T, Ozono K, Okada S. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia. J Hum Genet 2001; 46: 41-44. (Pubitemid 32178925)
24. Chikatsu N, Watanabe S, Takeuchi Y, Muraosa Y, Sasaki S, Oka Y, Fukumoto S, Fujita T. A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene. Endocr J 2003; 50: 91-96. (Pubitemid 36305852)
25. Tan YM, Cardinal J, Franks AH, Mun HC, Lewis N, Harris LB, Prins JB, Conigrave AD. Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor. J Clin Endocrinol Metab 2003; 88: 605-610. (Pubitemid 36207798)
26. Uckun-Kitapci A, Underwood LE, Zhang J, Moats-Staats B. A novel mutation (E767K) in the second extracellular loop of the calcium sensing receptor in a family with autosomal dominant hypocalcemia. Am J Med Genet 2005; 132A: 125-129. (Pubitemid 40093319)
27. Sato K, Hasegawa Y, Nakae J, Nanao K, Takahashi I, Tajima T, Shinohara N, Fujieda K. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab 2002; 87: 3068-3073. (Pubitemid 34816346)
28. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaître X, Paillard M, Planelles G, Déchaux M, Miller RT, Antignac C. Functional characterization of a calcium-sensing receptor in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002; 13: 2259-2266. (Pubitemid 34925236)
29. Hu J, Mora S, Weber G, Zamproni I, Proverbio MC, Spiegel AM. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor. J Bone Miner Res 2004; 19: 578-586. (Pubitemid 41071218)
30. Shiohara M, Mori T, Mei B, Brown EM, Watanabe T, Yasuda T. A novel gain-of-function mutation (F821L) in the transmembrane domain of calcium-sensing receptor is a cause of severe sporadic hypoparathyroidism. Eur J Pediatr 2004; 163: 94-98. (Pubitemid 38223392)